Leaflet CEENU 40mg soft capsules
Indicated for: cancer
Route of administration: oral
Substance: lomustine (antineoplastic agent)
ATC: L01AD02 (Antineoplastic and immunomodulating agents | Alkylating agents | Nitrosoureas)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Lomustine is a chemotherapy medication used to treat certain types of cancer, including brain tumors, Hodgkin's lymphoma, and other advanced cancers. It belongs to the class of alkylating agents and works by damaging the DNA of cancer cells, preventing them from multiplying.
The medication is taken orally, usually in capsule form, and the dosage is adjusted based on body weight and the type of cancer being treated. Treatment is carried out under the strict supervision of an oncologist.
Side effects may include nausea, vomiting, decreased blood cell counts, fatigue, and an increased risk of infections. It is important for patients to be regularly monitored to assess the effectiveness of the treatment and manage any adverse reactions.
Pregnant or breastfeeding women should not use lomustine, and patients must inform their doctor about any other medications or supplements they are taking.
General data about CEENU 40mg
- Substance: lomustine
- Date of latest medicines list: 01-07-2013
- Product code: W54014001
- Concentration: 40mg
- Pharmaceutical form: soft capsules
- Quantity: 20
- Product type: Generic medicine
- Prescription status: X